ParisK: Correlation of Imaging Techniques With Histology

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-08-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The possibility to identify the risk of rupture of a carotid plaque will have tremendous impact in clinical decision making. A vulnerable plaque is considered to have a large lipid rich necrotic core (LRNC), a thin fibrous cap, the presence of inflammatory cells, intraplaque haemorrhage and/or neovascularisation (vasa vasorum). The investigators aim to validate imaging of plaque vulnerability with histology. Previous studies have evaluated the use of imaging to assess carotid plaque vulnerability, mostly showing a good correlation between imaging and histology and/or clinical characteristics. However, they have focused on single modalities, (magnetic resonance imaging \[MRI\], multidetector-row computed tomography (MDCT), ultrasonography (US) or transcranial Doppler (TCD), and have used relatively small cohorts

The primary goal of this study is to investigate whether there is a correlation between neovascularisation in the carotid atherosclerotic plaque as observed with 3.0 Tesla dynamic contrast-enhanced MRI and histology. Moreover, the investigators aim to investigate the correlation between the volume of the LRNC as determined by dual-energy CT and histology.

Secondly, the investigators will investigate the correlation between the volume of the LRNC, the fibrous cap status and the volume of the calcifications determined by MRI versus histology, the correlation between number of microembolisms and fibrous cap status and the correlation between the deformation pattern seen with ultrasound and the volume of the LRNC.

The imaging parameters showing good correlation with plaque vulnerability characteristics can be used for further analysis in assessing the vulnerable plaque

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Plaque Imaging in Routine Care to Detect Intraplaque Hemorrhage

NCT06749106

Acute Ischemic Stroke

RECRUITING

Assessment of Plaque Vulnerability Using a Novel Technique: Multi-spectral PhotoAcoustic Imaging.

NCT04763603

Neurology

TERMINATED

Molecular Imaging of Inflammation With 18F-PBR06 to Identify Unstable Carotid Plaques in Patients With Stroke

NCT02513589

Stroke

TERMINATED PHASE2

Molecular Imaging of Plaque Vulnerability

NCT02640313

Plaque, Atherosclerotic

UNKNOWN PHASE3

PET-MRI Imaging in Patients With Acute Neurovascular Syndrome

NCT03215563

Stroke Carotid Stenosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Plaque, Atherosclerotic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients scheduled for CEA

All patients who are scheduled for carotid endarterectomy (CEA)

Magnetic Resonance Imaging (MRI)

Intervention Type OTHER

Multi-sequence MR protocol

Dual-Energy Computed Tomography (DECT)

Intervention Type RADIATION

Ultrasound

Intervention Type OTHER

Transcranial doppler

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnetic Resonance Imaging (MRI)

Multi-sequence MR protocol

Intervention Type OTHER

Dual-Energy Computed Tomography (DECT)

Intervention Type RADIATION

Ultrasound

Intervention Type OTHER

Transcranial doppler

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

3.0 T Philips Achieva Siemens Flash Philips IU22 Hemodynamics AG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with a carotid artery stenosis, who are scheduled for carotid endarterectomy
* Age 18 years or older (no maximum age)
* Informed consent by signing informed consent form regarding this study

1. Symptomatic carotid artery stenosis 70-99% within 3 months of neurological symptoms
2. Symptomatic carotid artery stenosis 50-99% in man within 2 weeks of neurological symptoms
3. Asymptomatic carotid artery stenosis 70-99% with contralateral occlusion

Exclusion Criteria

* Severe co-morbidity, dementia or pregnancy
* Standard contra-indications for MRI (ferromagnetic implants like pacemakers or other electronic implants, metallic eye fragments, vascular clips, claustrophobia, etc.)
* Patients who have a documented allergy to MRI or CT contrast media
* Patients with a renal clearance \<30 ml/min are not eligible to undergo contrast-enhanced MRI
* Patients with a renal clearance \<60 ml/min are not eligible to undergo CT
* Surgery planned within 4 days of inclusion

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No